article thumbnail

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

SUMMARY: Allowing Medicare to negotiate drug prices is popular with voters because the media has been focused on the high price of some drugs, but this measure won’t lead to lower healthcare costs. Prescription drug costs are only a small part of healthcare costs, and by 2028 U.S. healthcare spending will reach $6.2

article thumbnail

EMA publishes EU strategy to 2028

European Pharmaceutical Review

A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). The overarching theme of our updated strategy to 2028 is that of change – rapid, somewhat unpredictable but nonetheless full of promise.

article thumbnail

US Healthcare Industry Sectors: Facts, Trends, & Statistics

Medico Reach

Infographic content: The onset of the COVID-19 pandemic has pushed significant growth in the US Healthcare Industry, with 2022 being the year of consumer influence. With higher interoperability levels and significantly better price transparency for medical bills and drugs, the US healthcare industry is dead set on growth.

article thumbnail

Your Guide to Virtual Reality Reimbursement in the U.S. Healthcare Market

Nixon Gwilt Law

As a law firm focused specifically on healthcare innovation, we get really excited about developing areas of the healthcare industry. Digital health companies building VR solutions often ask us this question, and if you are a founder or executive looking for ways to commercialize your VR platform for healthcare providers in the U.S.,

article thumbnail

The Future of Assistive Technology in Healthcare Industry

Medico Reach

Telemedicine, cloud computing, big data, and 3D printing are well-known technologies in the healthcare sector. Assistive technology in healthcare is a promising yet comparatively less leveraged resource in today’s era. Experts project this tech segment to surpass a whopping USD 28 billion mark by 2028. Prostheses.

article thumbnail

Pharma’s reputational high will be short-lived

World of DTC Marketing

A great example of pharma’s profiteering is biosimilar drugs which cost a lot and add billions of dollars to healthcare costs. Another biologic, Enbrel, on the market since 1998, will not have its $5 billion in sales challenged until the end of 2028. Political pressure was mounting in the US, the most profitable market.

Pharma 186
article thumbnail

Evolution of IOT in Healthcare industry

Medico Reach

Due to this evolution of IoT in Healthcare, the market is expected to cross $190 Billion by 2028. IoT in Healthcare: Market reports. of the market share of IoT technologies in healthcare belongs to medical devices. 34% of the top Healthcare Professionals also feel that IoT productivity will rise. between 2022-2027.